Midatech Pharma PLC (LSE:MTPH) - Overview

Stock Report

Midatech Pharma PLC MTPH

Last Price
GBX117.50

Day Change
0.00|0.00%

As of 09/12/2016
16:05:59 GMT | GBX
Minimum 15 Minutes Delay.

Last Close117.50p
Day Range117.00 - 117.30
Mkt Cap57.22Mil
52-Wk Range100.51 - 239.50
Yield %0.00
ISINGB00BRTL9B63
Volume5,714
P/E-4.27
P/S24.12
P/CF-2.68

Share Price

Total Returns 09/12/2016

 Chg (%)  
More ...
Midatech Pharma PLC-0.84 
FTSE 100 TR GBP1.05
 
Financials
201320142015
More ...
Income Statement
Turnover0.150.161.38
Operating Profit-4.50-9.69-12.92
Net Profit-4.08-8.82-10.10
Reported EPS-71.00-98.00-36.00
Balance Sheet
Current Assets4.1031.6320.33
Non Current Assets1.0815.0443.71
Total Assets5.1746.6664.04
Current Liabilities2.302.839.10
Total Liabilities4.414.6717.15
Total Equity0.7641.9946.89
Cash Flow
Operating Cash Flow-5.02-6.25-13.07
Net Change in Cash2.2527.94-14.17
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
2016-12.73-15.31--7.67---
2017-9.68-7.71--15.23---
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
18/12/2015PurchaseDr. Jim Phillips204.009601,958.00

Company Profile

Midatech Pharma PLC is a nanomedicine company engaged in the development and commercialization of multiple therapeutic products to enhance the delivery of medicines in diseases with high unmet medical needs.
 

Sector

Biotechnology

Market Position

1031 of 1863 Companies

Index

FTSE AIM All Share

Outlook

(02/09/2016) "...we continue to look at opportunities to build value for shareholders and look to the future with optimism"

Next Event 31/12/2016

Next year end (to be reported)
Ratios
CompSecMkt
More ...
PER (E)-14.3813.2516.09
Div Yld (E)0.004.244.23
PEG (E)0.002.760.59
ROCE-62.93202.9879.03
Op Mrgn-646.69-16.14-13.33
EPS Grwth0.0012.0522.92
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00

Broker Sentiment

Strong Buy0
Buy2
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanMr. Rolf Stahel
Chief Executive OfficerDr. Jim Phillips
Finance Director & Company SecretaryMr. Nick Robbins-Cherry
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2016 Morningstar. All rights reserved.